Client/Funder: European Commission

Brief summary of work:  This project sought to produce non-binding guidance, published by the European Commission in 2023, which provides an overview of existing good practices and advice on reducing workers' exposure to hazardous medicinal products. The aim of the guide is to increase awareness of the risks of hazardous medicinal products and increase the uptake of good practices for the handling of HMPs across the European Union (EU). It also serves as a useful reference point and support for training activities. The guide is intended for all types of organisations, regardless of size, in both the public and private sectors, and provides practical information for workers, employers, public authorities, safety experts and occupational physicians.

Collaborative partners: RPA Prague Czech Republic, Risk & Policy Analysts Ltd (RPA) United Kingdom

Project website: https://osha.europa.eu/en/legislation/guidelines/guidance-safe-management-hazardous-medicinal-products-work